The SGLT family-sodium-glucose transporters with roles beyond glucose and the kidney.
作者信息
Mathew David, Davidson Sean, Yellon Derek
机构信息
The Hatter Cardiovascular Institute, University College London, London, UK.
出版信息
J Cell Mol Med. 2024 Mar;28(6):e18152. doi: 10.1111/jcmm.18152.
Abstract
摘要
相似文献
1
The SGLT family-sodium-glucose transporters with roles beyond glucose and the kidney.
J Cell Mol Med. 2024 Mar;28(6):e18152. doi: 10.1111/jcmm.18152.
2
Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects.
Diabetes Obes Metab. 2017 Sep;19(9):1322-1326. doi: 10.1111/dom.13003. Epub 2017 Jul 13.
3
Co-localization of the sodium-glucose co-transporter-2 channel (SGLT-2) with endothelin ETA and ETB receptors in human cardiorenal tissue.
Biosci Rep. 2024 Jun 26;44(6). doi: 10.1042/BSR20240604.
4
Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter.
FEBS Lett. 2012 Feb 3;586(3):248-53. doi: 10.1016/j.febslet.2011.12.027. Epub 2011 Dec 30.
5
Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease.
JAMA Netw Open. 2024 Jan 2;7(1):e2350050. doi: 10.1001/jamanetworkopen.2023.50050.
6
Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications.
Int Braz J Urol. 2019 Jan-Feb;45(1):169-178. doi: 10.1590/S1677-5538.IBJU.2018.0271.
7
Effect of sodium-glucose cotransporter 2 inhibitors on the rate of decline in kidney function: A systematic review and meta-analysis.
J Diabetes. 2023 Jan;15(1):58-70. doi: 10.1111/1753-0407.13348. Epub 2023 Jan 6.
8
Status of glucose transporters in the mammalian kidney and renal development.
Ren Fail. 2001 May-Jul;23(3-4):301-10. doi: 10.1081/jdi-100104714.
9
The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes.
Curr Med Res Opin. 2019 Jul;35(7):1283-1295. doi: 10.1080/03007995.2019.1576479. Epub 2019 Feb 15.
10
Human Glucose Transporters in Renal Glucose Homeostasis.
Int J Mol Sci. 2021 Dec 16;22(24):13522. doi: 10.3390/ijms222413522.
引用本文的文献
1
SGLT2 Inhibitors: From Structure-Effect Relationship to Pharmacological Response.
Int J Mol Sci. 2025 Jul 19;26(14):6937. doi: 10.3390/ijms26146937.
2
The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications.
Front Pharmacol. 2025 Jan 9;15:1510080. doi: 10.3389/fphar.2024.1510080. eCollection 2024.
本文引用的文献
1
Safety and efficacy of sotagliflozin in patients with type II diabetes mellitus and chronic kidney disease: a meta-analysis of randomized controlled trials.
J Nephrol. 2024 May;37(4):881-896. doi: 10.1007/s40620-023-01818-2. Epub 2023 Dec 23.
2
Sotagliflozin: Efficacy, Safety, and Potential Therapeutic Applications in Heart Failure.
Ann Pharmacother. 2024 Sep;58(9):935-946. doi: 10.1177/10600280231211179. Epub 2023 Nov 28.
3
Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function.
Eur J Pharmacol. 2023 Jun 15;949:175720. doi: 10.1016/j.ejphar.2023.175720. Epub 2023 Apr 11.
4
Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients.
Front Pediatr. 2022 Nov 23;10:1071464. doi: 10.3389/fped.2022.1071464. eCollection 2022.
5
Renal Tubular Handling of Glucose and Fructose in Health and Disease.
Compr Physiol. 2021 Dec 29;12(1):2995-3044. doi: 10.1002/cphy.c210030.
6
SGLT1 Inhibition Attenuates Apoptosis in Diabetic Cardiomyopathy via the JNK and p38 Pathway.
Front Pharmacol. 2021 Jan 12;11:598353. doi: 10.3389/fphar.2020.598353. eCollection 2020.
7
Intestinal sodium/glucose cotransporter 3 expression is epithelial and downregulated in obesity.
Life Sci. 2021 Feb 15;267:118974. doi: 10.1016/j.lfs.2020.118974. Epub 2020 Dec 30.
8
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.
9
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.
Pflugers Arch. 2020 Sep;472(9):1177-1206. doi: 10.1007/s00424-020-02433-x. Epub 2020 Aug 7.
10
Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence.
J Cell Mol Med. 2020 Feb;24(3):2109-2122. doi: 10.1111/jcmm.14233. Epub 2019 Mar 30.
Zotero 插件